Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO

Springer Science and Business Media LLC - Tập 24 - Trang 769-780 - 2014
Torquil Watt1, Giuseppe Barbesino2, Jakob Bue Bjorner3, Steen Joop Bonnema4, Branka Bukvic5, Russell Drummond6, Mogens Groenvold7, Laszlo Hegedüs4, Valeska Kantzer8, Kathryn E. Lasch9, Claudio Marcocci10, Anjali Mishra11, Romana Netea-Maier12, Merel Ekker12, Ivan Paunovic5, Terence J. Quinn6, Åse Krogh Rasmussen1, Audrey Russell13, Mayilvaganan Sabaretnam14, Johannes Smit12, Ove Törring15, Vladan Zivaljevic5, Ulla Feldt-Rasmussen1
1Department of Endocrinology, Copenhagen University Hospital Rigshospitalet, Copenhagen Ø, Denmark
2Massachusetts General Hospital, Boston, USA
3QualityMetric, Lincoln, USA
4Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark
5Clinical Centre of Serbia, Belgrade, Serbia
6Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK
7Research Unit, Department of Palliative Medicine, Bispebjerg Hospital and Department of Health Service Research, University of Copenhagen, Copenhagen, Denmark
8Health Research Associates, Inc, Mountlake Terrace, USA
9Pharmerit International, Bethesda, USA
10University Department of Clinical and Experimental Medicine, University of Pisa, and Endocrine Unit 2, University Hospital of Pisa, Pisa, Italy
11Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
12Department of Internal Medicine, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands
13University College Cork, Cork, Ireland
14Christian Medical College, Vellore, India
15Institution for Clinical Science and Education, Karolinska Institutet Södersjukhuset, Stockholm, Sweden

Tóm tắt

Thyroid diseases are common and often affect quality of life (QoL). No cross-culturally validated patient-reported outcome measuring thyroid-related QoL is available. The purpose of the present study was to test the cross-cultural validity of the newly developed thyroid-related patient-reported outcome ThyPRO, using tests for differential item functioning (DIF) according to language version. The ThyPRO consists of 85 items summarized in 13 multi-item scales and one single item. Scales cover physical and mental symptoms, well-being and function as well as social and daily function and cosmetic concerns. Translation applied standard forward–backward methodology with subsequent cognitive interviews and reviews. Responses (N = 1,810) to the ThyPRO were collected in seven countries: UK (n = 166), The Netherlands (n = 147), Serbia (n = 150), Italy (n = 110), India (n = 148), Denmark (n = 902) and Sweden (n = 187). Translated versions were compared pairwise to the English version by examining uniform and nonuniform DIF, i.e., whether patients from different countries respond differently to a particular item, although they have identical level of the concept measured by the item. Analyses were controlled for thyroid diagnosis. DIF was investigated by ordinal logistic regression, testing for both statistical significance and magnitude (ΔR 2 > 0.02). Scale level was estimated by the sum score, after purification. For twelve of the 84 tested items, DIF was identified in more than one language. Eight of these were small, but four were indicative of possible low translatability. Twenty-one instances of DIF in single languages were identified, indicating potential problems with the particular translation. However, only seven were of a magnitude which could affect scale scores, most of which could be explained by sample differences not controlled for. The ThyPRO has good cross-cultural validity with only minor cross-cultural invariance and is recommended for use in international multicenter studies.

Tài liệu tham khảo